chr20-23036182-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001052.4(SSTR4):c.699C>T(p.Leu233=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00611 in 1,611,514 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0087 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0058 ( 59 hom. )
Consequence
SSTR4
NM_001052.4 synonymous
NM_001052.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.48
Genes affected
SSTR4 (HGNC:11333): (somatostatin receptor 4) Somatostatin acts at many sites to inhibit the release of many hormones and other secretory proteins. The biologic effects of somatostatin are probably mediated by a family of G protein-coupled receptors that are expressed in a tissue-specific manner. SSTR4 is a member of the superfamily of receptors having seven transmembrane segments and is expressed in highest levels in fetal and adult brain and lung. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 20-23036182-C-T is Benign according to our data. Variant chr20-23036182-C-T is described in ClinVar as [Benign]. Clinvar id is 782169.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.48 with no splicing effect.
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00584 (8527/1459188) while in subpopulation MID AF= 0.0512 (295/5762). AF 95% confidence interval is 0.0464. There are 59 homozygotes in gnomad4_exome. There are 4420 alleles in male gnomad4_exome subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 6 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SSTR4 | NM_001052.4 | c.699C>T | p.Leu233= | synonymous_variant | 1/1 | ENST00000255008.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SSTR4 | ENST00000255008.5 | c.699C>T | p.Leu233= | synonymous_variant | 1/1 | NM_001052.4 | P1 | ||
ENST00000440921.6 | n.827-2041C>T | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00872 AC: 1327AN: 152208Hom.: 6 Cov.: 33
GnomAD3 genomes
AF:
AC:
1327
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00726 AC: 1791AN: 246582Hom.: 19 AF XY: 0.00750 AC XY: 1004AN XY: 133918
GnomAD3 exomes
AF:
AC:
1791
AN:
246582
Hom.:
AF XY:
AC XY:
1004
AN XY:
133918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00584 AC: 8527AN: 1459188Hom.: 59 Cov.: 30 AF XY: 0.00609 AC XY: 4420AN XY: 725996
GnomAD4 exome
AF:
AC:
8527
AN:
1459188
Hom.:
Cov.:
30
AF XY:
AC XY:
4420
AN XY:
725996
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00869 AC: 1324AN: 152326Hom.: 6 Cov.: 33 AF XY: 0.00861 AC XY: 641AN XY: 74478
GnomAD4 genome
AF:
AC:
1324
AN:
152326
Hom.:
Cov.:
33
AF XY:
AC XY:
641
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
21
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 15, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at